News

Tariff wars to hit popular US-made drugs in China, regulator data shows
Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, ...
MercoPress1d
WHO wants data from China on respiratory disease affecting children
Faced with this situation, the WHO issued a statement “on the notification of clusters of respiratory illness in children in northern” China ... syncytial virus (RSV) and SARS-CoV-2 (the ...
US CDC advisers recommend lowering the age for RSV shots to 50-59 years
The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of ...
PharmExec6d
ArkBio’s Ziresovir Demonstrates Clinical Efficacy in Hospitalized Infants with Respiratory Syncytial Virus
Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...
CBS News11d
China says it's raising tariffs on U.S. goods to 125%
China said Friday that it was raising tariffs on U.S. goods from 84% to 125%, the latest development in the escalating trade war between the two countries. It said the higher tariffs would take ...
Benzinga.com5d
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
RSV causes 42K hospitalizations annually in adults aged 50–64, per U.S. study. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt ...
The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months
The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted ...